Narwhal Capital Management lowered its stake in Elevance Health, Inc. (NYSE:ELV – Free Report) by 13.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,275 shares of the company’s stock after selling 650 shares during the period. Narwhal Capital Management’s holdings in Elevance Health were worth $1,577,000 as of its most recent SEC filing.
Other large investors also recently made changes to their positions in the company. Raelipskie Partnership acquired a new stake in Elevance Health in the 3rd quarter worth approximately $26,000. PSI Advisors LLC acquired a new stake in shares of Elevance Health in the third quarter worth $27,000. Eastern Bank acquired a new stake in shares of Elevance Health in the third quarter worth $31,000. Dunhill Financial LLC boosted its holdings in shares of Elevance Health by 57.8% during the 3rd quarter. Dunhill Financial LLC now owns 71 shares of the company’s stock worth $37,000 after buying an additional 26 shares during the period. Finally, Peterson Financial Group Inc. acquired a new position in Elevance Health in the 3rd quarter valued at $44,000. Institutional investors own 89.24% of the company’s stock.
Elevance Health Stock Up 0.0 %
Shares of ELV opened at $401.43 on Monday. Elevance Health, Inc. has a 12 month low of $362.21 and a 12 month high of $567.26. The stock has a market cap of $93.10 billion, a price-to-earnings ratio of 14.63, a P/E/G ratio of 1.11 and a beta of 0.84. The company has a 50-day moving average price of $386.21 and a two-hundred day moving average price of $461.87. The company has a quick ratio of 1.50, a current ratio of 1.50 and a debt-to-equity ratio of 0.56.
Elevance Health Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 25th. Investors of record on Monday, March 10th will be issued a dividend of $1.71 per share. This is an increase from Elevance Health’s previous quarterly dividend of $1.63. This represents a $6.84 annualized dividend and a yield of 1.70%. The ex-dividend date is Monday, March 10th. Elevance Health’s dividend payout ratio (DPR) is currently 23.77%.
Analyst Ratings Changes
ELV has been the subject of a number of research analyst reports. TD Cowen cut their target price on shares of Elevance Health from $589.00 to $484.00 and set a “buy” rating for the company in a research report on Monday, October 21st. Raymond James set a $485.00 target price on Elevance Health in a research note on Friday, October 18th. Wells Fargo & Company dropped their price target on Elevance Health from $593.00 to $495.00 and set an “overweight” rating on the stock in a research report on Monday, November 4th. UBS Group lowered their price objective on shares of Elevance Health from $605.00 to $555.00 and set a “buy” rating on the stock in a research note on Friday, October 18th. Finally, Mizuho dropped their target price on shares of Elevance Health from $585.00 to $505.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 5th. Three research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $525.60.
Get Our Latest Research Report on Elevance Health
Elevance Health Company Profile
Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
See Also
- Five stocks we like better than Elevance Health
- Low PE Growth Stocks: Unlocking Investment Opportunities
- MP Materials: Rare Earth Elements Powering the EV Boom
- Ride Out The Recession With These Dividend Kings
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- 5 discounted opportunities for dividend growth investors
- Bloom Energy: Powering the Future With Decentralized Energy
Want to see what other hedge funds are holding ELV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV – Free Report).
Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.